Safety of Low-Dose Aprotinin in Coronary Artery Bypass Graft Surgery: A Single-Centre Investigation in 2436 Patients in Germany

By Kluth Mario  

Drug Safety, Vol. 31, Iss. 7, 2008-01 ,pp. : 617-626

Adis International

Access to resources Recommend Favorite

Effects of Remifentanil and Fentanyl on the Cell-mediated Immune Response in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery

By von Dossow V   Luetz A   Haas A   Sawitzki B   Wernecke KD   Volk HD   Spies CD  

The Journal of International Medical Research, Vol. 36, Iss. 6, 2008-11 ,pp. : 1235-1247

Field House Publishing

Access to resources Recommend Favorite

Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis and Meta-Regression Analysis of Placebo-Controlled Randomized Clinical Trials

By Hernandez Adrian V.  

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 2, 2011-04 ,pp. : 115-128

Adis International

Access to resources Recommend Favorite

Perioperative Safety of Aprotinin in Coronary Artery Bypass Graft Surgery: Is there Life After BART?

By Augoustides John G.  

Drug Safety, Vol. 31, Iss. 7, 2008-01 ,pp. : 557-560

Adis International

Access to resources Recommend Favorite

Use of Cardioselective β-Blockers in Patients with Chronic Obstructive Pulmonary Disease: a Meta-Analysis of Randomized, Placebo-controlled, Blinded Trials

By Ni Y   Shi G   Wan H  

The Journal of International Medical Research, Vol. 40, Iss. 6, 2012-11 ,pp. : 2051-2065

Field House Publishing

Access to resources Recommend Favorite